, of the 4th International Workshop-Conference on Gestational Diabetes Mellitus, vol.21, pp.1-167, 1997.

C. Billionnet, D. Mitanchez, A. Weill, J. Nizard, A. F. Hartemann et al., Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012, Diabetologia. avr, vol.60, issue.4, pp.636-680, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01592952

, Association des utilisateurs de dossiers informatisés en pédiatrie, obstétrique et gynécologie (Audipog)

, Réseau national d'information sur la naissance

, La santé périnatale en 2004-2005 : évaluation des pratiques médicales

, Extrait des mises à jour en Gynécologie et Obstétrique : recommandations pour la pratique clinique. Le diabète gestationnel, Collège national des gynécologues et obstétriciens français

P. M. Catalano, H. D. Mcintyre, J. K. Cruickshank, D. R. Mccance, A. R. Dyer et al., The Hyperglycemia and Adverse Pregnancy Outcome Study: Associations of GDM and obesity with pregnancy outcomes, Diabetes Care. 1 avr, vol.35, issue.4, pp.780-786, 2012.

A. Burguet, Long term outcome in children of mothers with gestational diabetes, J GynecolObstetBiolReprod (Paris). déc, vol.39, issue.8, pp.322-337, 2010.

O. Vérier-mine, Outcomes in women with history of gestational diabetes mellitus. Screening and prevention of type 2 diabetes mellitus. Literature review, J GynecolObstetBiolReprod (Paris). déc, vol.39, issue.8, pp.299-321, 2010.

E. Cosson, A. Benbara, I. Pharisien, M. T. Nguyen, A. Revaux et al., Diagnostic and prognostic performances over 9 years of a selective screening strategy for gestational diabetes mellitus in a cohort of 18,775 subjects, Diabetes Care. Mars, vol.36, issue.3, pp.598-603, 2013.

M. B. Landon, C. Y. Spong, E. Thom, M. W. Carpenter, S. M. Ramin et al., Randomized Trial of Treatment for Mild Gestational Diabetes, New England Journal of Medicine, vol.361, issue.14, pp.1339-1387, 2009.

C. A. Crowther, J. E. Hiller, J. R. Moss, A. J. Mcphee, W. S. Jeffries et al., Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes, New England Journal of Medicine. 16 juin, vol.352, issue.24, pp.2477-86, 2005.

S. Bartolo, A. Vambergue, and P. Deruelle,

, J GynecolObstetBiolReprod (Paris). févr, vol.45, issue.2, pp.105-116, 2016.

M. E. Inkster, T. P. Fahey, P. T. Donnan, G. P. Leese, G. J. Mires et al., Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies, BMC Pregnancy Childbirth, vol.6, p.30, 2006.

A. N. Sweeting, G. P. Ross, J. Hyett, L. Molyneaux, K. Tan et al., Baseline HbA1c to Identify High-Risk Gestational Diabetes: Utility in Early vs Standard Gestational Diabetes, J ClinEndocrinolMetab, vol.01, issue.1, pp.150-156, 2017.

C. Capula, T. Mazza, R. Vero, and G. Costante, HbA1c levels in patients with gestational diabetes mellitus: Relationship with pre-pregnancy BMI and pregnancy outcome, J Endocrinol Invest. déc, vol.36, issue.11, pp.1038-1083, 2013.

L. Mañé, J. A. Flores-le-roux, D. Benaiges, M. Rodríguez, M. I. Chillarón et al., Role of First-Trimester HbA1c as a Predictor of Adverse Obstetric Outcomes in a Multiethnic Cohort, J ClinEndocrinolMetab. 1 févr, vol.102, issue.2, pp.390-397, 2017.

B. E. Metzger, S. G. Gabbe, B. Persson, T. A. Buchanan, and P. A. Catalano, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy, International Association of Diabetes and Pregnancy Study Groups Consensus Panel, vol.33, pp.676-82, 2010.

L. J. Salomon, M. Duyme, J. Crequat, G. Brodaty, C. Talmant et al., French fetal biometry: reference equations and comparison with other charts

, UltrasoundObstetGynecol. août, vol.28, issue.2, pp.193-201, 2006.

R. Hughes, M. P. Moore, J. E. Gullam, K. Mohamed, and J. Rowan, An early pregnancy HbA1c ?5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care, vol.37, pp.2953-2962, 2014.

C. E. Eades, E. F. France, and J. Evans, Postnatal experiences, knowledge and perceptions of women with gestational diabetes, Diabet Med, vol.35, issue.4, pp.519-548, 2018.

V. W. Wong, S. Chong, S. Mediratta, and B. Jalaludin, Measuring glycated haemoglobin in women with gestational diabetes mellitus: How useful is it?, Aust N Z J ObstetGynaecol. juin, vol.57, issue.3, pp.260-265, 2017.

L. Mañé, J. A. Flores-le-roux, P. -. Botet, J. Gortazar, L. Chillarón et al., Is fasting plasma glucose in early pregnancy a better predictor of adverse obstetric outcomes than glycated haemoglobin?, Eur J ObstetGynecolReprodBiol. 9 janv, vol.234, pp.79-84, 2019.

S. N. Hinkle, M. Y. Tsai, S. Rawal, P. S. Albert, and C. Zhang, HbA1c Measured in the First Trimester of Pregnancy and the Association with, Gestational Diabetes. Sci Rep. 16 août, vol.8, issue.1, p.12249, 2018.

G. Ducarme, D. Du-roure, F. Grange, J. Vital, M. et al., Predictive factors of subsequent insulin requirement for glycemic control during pregnancy at diagnosis of gestational diabetes mellitus, Int J Gynaecol Obstet, vol.22, 2018.

, Poids de naissance (grammes) entre 25 et 42 SA. 3 ème , 10 ème , 50 ème , 90 ème et 97 ème centiles chez les garçons (figure A) et chez les filles (figure B), Annexe, vol.2